Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-12-009235
Filing Date
2012-02-15
Accepted
2012-02-15 19:43:34
Documents
1
Period of Report
2012-02-13

Document Format Files

Seq Description Document Type Size
1 rrd334127.html 4  
1 rrd334127.xml 4 11350
  Complete submission text file 0001181431-12-009235.txt   13355
Mailing Address
Business Address 1119 ST PAUL STREET BALTIMORE MD 21202 4102440115
NEW ENTERPRISE ASSOCIATES 10 L P (Reporting) CIK: 0001132326 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-50772 | Film No.: 12617360

Mailing Address 1119 ST PAUL STREET BALTIMORE MD 21202
Business Address 1119 ST PAUL STREET BALTIMORE MD 21202 4102440115
NEA PARTNERS 10 L P (Reporting) CIK: 0001236049 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-50772 | Film No.: 12617359

Mailing Address 9005 WESTSIDE PARKWAY ALPHARETTA GA 30004
Business Address 9005 WESTSIDE PARKWAY ALPHARETTA GA 30004 678-746-1100
INHIBITEX, INC. (Issuer) CIK: 0001274913 (see all company filings)

EIN.: 742708737 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)